StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Fortress Biotech (FBIO) PT Raised to $13 at Roth/MKM
August 14, 2024 5:06 AM
Roth/MKM analyst Jason Whittes raised the price target on Fortress Biotech (NASDAQ: FBIO) to $13.00 (from $10.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 10-Q Fortress Biotech, Inc. For: Jun 30
August 13, 2024 4:32 PM
Fortress Biotech (FBIO) Reports Q2 Loss of $0.73/sh
August 13, 2024 4:25 PM
Form 8-K Fortress Biotech, Inc. For: Aug 13
August 13, 2024 4:16 PM
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 13, 2024 4:05 PM
Form 10-Q MUSTANG BIO, INC. For: Jun 30
August 13, 2024 4:02 PM
Form 10-Q Checkpoint Therapeutics, For: Jun 30
August 12, 2024 4:41 PM
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 12, 2024 4:01 PM
Form 8-K Checkpoint Therapeutics, For: Aug 12
August 12, 2024 8:46 AM
Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
August 12, 2024 8:30 AM
